# Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic Dermatitis

> **NCT04211415** · PHASE1 · TERMINATED · sponsor: **Daiichi Sankyo Co., Ltd.** · enrollment: 8 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** DS-2741a
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04211415
- **Lead sponsor:** Daiichi Sankyo Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-13
- **Primary completion:** 2020-03-14
- **Final completion:** 2020-12-18
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Company decision of termination of the clinical program.
- **Last updated:** 2021-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04211415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04211415, "Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04211415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*